NitroMed to Report Financial Results for First Fiscal Quarter 2008
NitroMed zu myNews hinzufügen Was ist das?
NitroMed, Inc. (NASDAQ: NTMD), announced today that on Wednesday, May 7,
2008 it will release financial results for the Company’s
first fiscal quarter ended March 31, 2008. Following the release,
NitroMed will host a webcast and conference call to report on first
quarter performance and recent activities.
Event: Q1 2008 NitroMed, Inc. Earnings Call
Date: Wednesday, May 7, 2008
Time: 8:00 a.m. Eastern Standard Time
Access by Conference Call:
Domestic callers: Dial 888.713.4218
International callers: Dial 617.213.4870
Participant passcode: 24676784 #
Access by Webcast:
Go to www.nitromed.com for
live webcast link or
www.theconferencingservice.com/prereg/key.process?key=PQLTPTPLG
An audio replay of the earnings conference call will be available two
hours after the call and through June 7, 2008. The replay can be
accessed by dialing 888-286-8010. International callers should dial
617-801-6888. The replay passcode for all callers is 64165398. The
webcast will be archived on the Company’s
website for an indefinite period of time following the earnings call.
About NitroMed, Inc.
NitroMed of Lexington, Massachusetts is an emerging pharmaceutical
company and the maker of BiDil®
(isosorbide dinitrate/hydralazine hydrochloride), an orally administered
medicine available in the United States for the treatment of heart
failure in self-identified black patients. In this population, BiDil is
indicated as an adjunct to current standard therapies such as
angiotensin converting enzyme (ACE) inhibitors and beta blockers. There
is little experience in patients with New York Heart Association Class
IV heart failure. BiDil was approved by the U.S. Food and Drug
Administration, primarily on the basis of efficacy data from the Company’s
landmark A-HeFT (African American Heart Failure Trial) clinical trial
and is marketed by NitroMed through a specialty medicines sales
organization.
For full prescribing information, visit: www.BiDil.com.
BiDil is a registered trademark of NitroMed, Inc.
